Cardinal Health Beats Estimates, Authorizes $5 Billion Share Buyback and Strong FY27 Outlook

Key Facts

In a move reflecting robust operational performance within the healthcare sector, Cardinal Health reported strong financial results for the fourth quarter of fiscal year 2026, driven by revenue growth and operational efficiency. According to reports, the company's revenue increased by 6% to reach $63.7 billion during the quarter, while non-GAAP diluted earnings per share (EPS) saw a significant 40% increase. These results were further bolstered by the board of directors' approval of an incremental $5.0 billion share repurchase authorization, signaling management's confidence in future cash flows.

These positive results come as the company sets ambitious targets for the future, issuing non-GAAP EPS growth guidance of 13% to 15% for fiscal year 2027. This optimistic outlook suggests continued growth in the sector despite broader economic challenges. Based on available financial data, this strong performance is driven by sales growth and one-time positive impacts related to tariff refunds, positioning the company competitively relative to its market peers.

Regarding market performance, CAH stock stood at $237.18 at the close of August 10, 2026, having reached a day high of $239.54. Traders are currently monitoring support levels around the $235 mark, which was the day's low in the most recent session. Looking at the economic calendar, there are no direct upcoming catalysts for the company in the next seven days, but the market will remain focused on how the massive share buyback program influences stock momentum in the near term.